SENSEX NIFTY

Glaxosmithkline

Sep 30, 2014 at 11:45 | Source: Moneycontrol.com
Brokerage house Firstcall Research is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target price of Rs 5815 in its research report dated September 25, 2014.
Sep 17, 2014 at 13:17 | Source: CNBC-TV18
Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have NCC, Zee Entertainment, Hero MotoCorp, Bajaj Auto, IRB Infrastructure, Biocon, Dr. Reddy and GSK Pharma.
Sep 17, 2014 at 13:11 | Source: CNBC-TV18
The DRL-GSK deal was to sell branded generic formulations in emerging markets and was entered into in 2009.
Sep 17, 2014 at 13:01 | Source: CNBC-TV18
Praful Bohra of Nirmal Bang Institutional Equities feels Lupins deal with Merck Serano will help the former to make way into incremental markets. Further, he has a positive call on the stock, as he believes recent initiatives taken by the pharma major will be beneficial for business in medium term.
Sep 16, 2014 at 09:57 | Source: CNBC-TV18
Neelkanth Mishra, Credit Suisse says consumption remains a secular growth story in India with years of catch up to even other emerging markets.
Sep 03, 2014 at 15:59 | Source: Moneycontrol.com
GlaxoSmithkline Consumer Healthcare Ltd has submitted to BSE a copy of the minutes of the 55th Annual General Meeting (AGM) of the Company held on August 07, 2014.
Sep 03, 2014 at 11:43 | Source: Moneycontrol.com
On Monday, Mumbai-based generic drugmaker Cipla launched the aerosol copy of GlaxoSmithKlines anti-asthma inhaler Adviar in two small European markets Germany and Sweden but the move could potentially serve as a precursor to a crack at more lucrative markets such as the US and the UK.
Sep 02, 2014 at 10:22 | Source: Moneycontrol.com
Though analysts are impressed by its earlier- than-expected launch, most of them have not yet upgraded Cipla yet. Credit Suisse maintains a neutral rating on it stating base case is already priced in. According to the brokerage, Germany and Sweden are small markets but the launch signifies approval in the UK could be expected by FY15-end.
Aug 30, 2014 at 14:32 | Source: CNBC-TV18
Last week, GSK consumer healthcare re-launched it's flagship health drink Horlicks with a new logo, packaging and commercial. Pavni Mittal of Storyboard caught up with Jayant Singh to understand the changes made to the brand and how it would be marketed.
Aug 28, 2014 at 10:04 | Source: Reuters
In addition, a steering committee made up of senior officials from NIH and the Department of Defense last week approved the first step toward using three advanced laboratories to manufacture Ebola vaccines and treatments, a person familiar with the planning said.
Messages on Glaxosmithkline »

arinshare

Gold Member

6 Followers

MF Investment Help  

Dear Soporofic, I take fancy of two stocks - GlaxoSmithKline Pharmaceuticals and GlaxoSmithKline Consumer Healthcare. Please share your stand on its future prospects. Another point I like to know how do you buy or pick stock right now at this life time high market? What is your conviction

4.08 PM Jul 6th

Web Messenger

Platinum Member

242499 Followers

GlaxoSmithKline  

Source:BBC - Allegations that pharmaceutical giant GlaxoSmithKline (GSK) systematically bribed doctors in China are credible, says an investigator hired by the firm. Peter Humphrey was hired only to investigate who was behind a suspected smear campaign against GSK. But after he finished his report

3.50 PM Jul 4th

Web Messenger

Platinum Member

242499 Followers

GlaxoSmithKline  

Source:BBC - To observers of China`s contemporary business culture it will come as no great surprise that the latest twist in GlaxoSmithKline`s China crisis is a sex tape. The secret filming of business, political and love rivals in intimate situations is now commonplace in China and motivations

3.50 PM Jul 4th

Expert Chartist

Platinum Member

9947 Followers

GlaxoSmithKline  

At 12:00 hrs GlaxoSmithKline has formed a bearish bar reversal chart pattern today. A Bearish Bar Reversal occurs when today\'s high is higher than its previous day high and the current price / today\'s close is lower than its previous day close.

12.00 PM Jul 4th

Omar_An

Silver Member

0 Follower

GlaxoSmithKline  

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline.

11.09 AM Jul 4th

PipaDove

New Member

0 Follower

GlaxoSmithKline  

3000 just round the corner. Buy and wait! - My target for GlaxoSmithKline is Rs 3000 for the short term with a stoploss of Rs 2545

10.42 AM Jul 4th

BSE/NSE Announcer

Platinum Member

4457 Followers

GlaxoSmith Con  

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that in accordance with the Companys Policy on Insider Trading, the date of commencement of closing of "Trading Window" shall be from July 03, 2014 and shall end 24 hours after public announcement of the Quarterly Financial Result

5.40 PM Jul 2nd

GlaxoSmithKline  

GlaxoSmithKline is a Sell - My target for GlaxoSmithKline is Rs 25120 for the short term with a stoploss of Rs 560

2.47 PM Jun 30th

Market Statistician

Platinum Member

10257 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals has touched a 52-week low of Rs 2,351.60. At 15:13 hrs, the share was quoting at Rs 2,466.00, down Rs 9.55, or 0.39%. See more

3.15 PM Jun 26th

Market Statistician

Platinum Member

10257 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals has touched a 52-week low of Rs 2,351.60. At 13:13 hrs, the share was quoting at Rs 2,460.10, down Rs 15.45, or 0.62%. See more

1.15 PM Jun 26th

News across the web »
Sep 25, 2014 at 15:22 | Source: BBC
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.